http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000507926-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-22 |
| filingDate | 1997-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2000-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2000507926-A |
| titleOfInvention | 2-thioxotetrahydropyrimidin-4-one derivatives |
| abstract | (57) Abstract: The present invention provides a therapeutic composition for increasing HDL cholesterol levels and for treating atherosclerotic conditions such as dyslipoproteinemia and coronary heart disease. -Thioxotetrahydropyrimidin-4-one derivatives. The compounds of the present invention have the formula (a): Wherein R is C 1 -C 6 alkyl or C 2 -C 6 alkenyl; R 1 , R 2 and R 3 are independently hydrogen, halogen or lower alkyl. |
| priorityDate | 1996-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 107.